Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ISRCTN21853061) titled 'Investigating whether prolonged antibiotics can prevent permanent Pseudomonas infection in bronchiectasis' on Jan. 23.
Study Type: Interventional
Study Design:
Open randomized controlled parallel-group trial (Efficacy, Safety)
Primary Sponsor: University of Dundee
Condition:
Bronchiectasis
Respiratory
Intervention:
Participants will be assigned in a 1:1 ratio to receive eradication treatment plus background therapy or background therapy only. Participants will be allocated to an arm using a minimisation algorithm, with factors for centre, long-term use of macrolides, and first isolation vs new isolation foll...